Anavex Life Sciences (AVXL) Tops Q4 EPS by 3c

Anavex Life Sciences (NASDAQ: AVXL) reported Q4 EPS of ($0.12), $0.03 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Anavex Life Sciences (AVXL) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• CVG to join Russell 2000 and Russell 3000 indexes June 26